DRIVE Meeting 2027 Agenda
The Biology of DRIVE
Connecting ancestral biology, representative clinical research, patient outcomes, and practical strategies for improving DRIVE scores.
Friday, March 12th, 2027
Meeting Chair: Ruemu E. Birhiray
| Time | Session Title |
|---|---|
| 6:30 AM - 7:00 AM | Continental Breakfast |
| 7:00 AM - 7:10 AM | The Biology of DRIVE: Connecting Discovery, Representation, and Better Care Ruemu E. Birhiray, MD |
| 7:20 AM - 7:40 AM | Beyond the Average Patient: Ancestral Genomic Variation and Its Implications for Hematologic Cancer Care Andrew Hantel, MD, MPH |
| 7:40 AM - 8:00 AM | The Signals of Senescence: SASP, Ancestry, and the Cancer Microenvironment Sanket Shah, PhD |
| 8:00 AM - 8:20 AM | Duffy-Null, Different Decisions: Interpreting Blood Counts and Outcomes in Multiple Myeloma Lauren E. Merz, MD |
| 8:20 AM - 8:35 AM | From Biological Variation to Clinical Action: Questions and Panel Discussion |
| 8:35 AM - 8:55 AM | Whose Evidence Gets Heard? Ancestry Representation in Publications and Scientific Presentations Catherine Lai, MD, MPH |
| 8:55 AM - 9:15 AM | Artificial Intelligence at the Intersection: Using Ancestry and AI to Build More Representative Clinical Trials Seungtaek Lee |
| 9:15 AM - 9:30 AM | Raising the Score, Strengthening the Evidence: Questions and Panel Discussion |
| 9:30 AM - 9:40 AM | Coffee Break |
| 9:40 AM - 10:00 AM | When DRIVE Fails: Duty of Care, Patient Harm, and Legal Accountability Dayna Bowen Matthew, JD, PhD, or Michelle Mello, JD, PhD² |
| 10:00 AM - 10:20 AM | The Cost of Being Unrepresented: What Patients Lose When Evidence Leaves Them Out Joan Reede, MD, or Merlin Chowkwanyun, PhD, MPH |
| 10:20 AM - 10:40 AM | Who Delivers the Care Matters: Representation, Cultural Alignment, and Trust in the Healthcare Team Lisa Cooper, MD, MPH |
| 10:40 AM - 10:55 AM | When Evidence and Care Fall Short: Questions and Panel Discussion |
| 10:55 AM - 11:05 AM | Coffee Break |
| 11:05 AM - 11:35 AM | Keynote Conversation: The Next Chapter in DRIVE — From Commitment to Measurable Change Robert Winn, MD |
| 11:35 AM - 11:50 AM | Evidence That Serves Every Patient: A Public Policy Approach to Cancer Treatment Decisions Renuka Iyer, MD |
| 11:50 AM - 12:05 PM | Opening the Trial Door: Less Red Tape, Greater Access, and a Global Coalition for Representative Clinical Trials Ishwaria Subbiah, MD, MS, FASCO |
| 12:05 PM - 12:20 PM | Setting the Standard: National Organizations, Data Reporting, and Abstract Selection Belinda Avalos, MD |
| 12:20 PM - 12:35 PM | Measuring What Matters: Biostatistical Advances and the Next DRIVE Calculator Todd Burus, PhD, MAS |
| 12:35 PM - 12:55 PM | Tomorrow's Steps, Today's Commitments: Questions and Closing Panel Discussion |
| 12:55 PM - 1:00 PM | Closing Remarks Ruemu E. Birhiray, MD |
| 1:00 PM | Luncheon |

